Hence, the scope of this review is to gather and systematize the information available regarding the impact of LAT1 and ASCT2 related miRNAs in CRC development and establish a profile with potential application to be used as a therapeutic agent through in silico analysis combined with a literature review (Figure 2). The gene discussed is SLC1A5; the disease is colorectal carcinoma.